Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients

Diana Luísa Almeida-Nunes, Ana Mendes-Frias, Mariana Nunes, Verónica Ferreira, Cláudia Lobo, Paula Monteiro, Miguel Henriques Abreu, Carla Bartosch, Claudia Nobrega, Ricardo Jorge Dinis-Oliveira, Ricardo Silvestre, Sara Ricardo · 2026

Read Anti-PD-1 Treatment Restores Effector Function in Exhausted-like T Cells from Malignant Ascites of Ovarian Cancer Patients by Diana Luísa Almeida-Nunes, Ana Mendes-Frias, Mariana Nunes, Verónica Ferreira, Cláudia Lobo, Paula Monteiro, Miguel Henriques Abreu, Carla Bartosch, Claudia Nobrega, Ricardo Jorge Dinis-Oliveira, Ricardo Silvestre, Sara Ricardo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13511107.txt.

Description

Twelve authors led by Diana Almeida-Nunes test whether a checkpoint drug can wake worn T cells in the belly fluid of ovarian cancer patients. That fluid bathes the tumour and brews a pro-fire soup that helps it grow. Twenty-two fresh, un-treated cases of the harsh kind gave fluid for the read. Cell kinds and fire marks were read by flow sorts in each cup.

Fast-loss patients held the most fire-rich fluid in the set. Their T cells bore worn marks and weak kill acts in the dish tests. The PD-1 block drug then woke those acts back up in the lab. Fluid reads may sort who gains from such drugs pre-care.

Catalog record

CREATORDiana Luísa Almeida-Nunes, Ana Mendes-Frias, Mariana Nunes, Verónica Ferreira, Cláudia Lobo, Paula Monteiro, Miguel Henriques Abreu, Carla Bartosch, Claudia Nobrega, Ricardo Jorge Dinis-Oliveira, Ricardo Silvestre, Sara Ricardo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13511107

Browse the full library · About the Tower of Babel